<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ANP</journal-id>
<journal-id journal-id-type="hwp">spanp</journal-id>
<journal-title>Australian &amp; New Zealand Journal of Psychiatry</journal-title>
<issn pub-type="ppub">0004-8674</issn>
<issn pub-type="epub">1440-1614</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0004867413491162</article-id>
<article-id pub-id-type="publisher-id">10.1177_0004867413491162</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Correspondence</subject>
<subj-group subj-group-type="heading">
<subject>Commentaries</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Biomarkers in DSM-5: Lost in translation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Carroll</surname><given-names>Bernard J</given-names></name>
</contrib>
<aff id="aff1-0004867413491162">Pacific Behavioral Research Foundation, Carmel, USA</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-0004867413491162">Bernard J Carroll, Pacific Behavioral Research Foundation, 100 Del Mesa Carmel, Carmel, CA 93923, USA. Email: <email>bcarroll40@comcast.net</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>7</month>
<year>2013</year>
</pub-date>
<volume>47</volume>
<issue>7</issue>
<fpage>676</fpage>
<lpage>678</lpage>
<permissions>
<copyright-statement>© The Royal Australian and New Zealand College of Psychiatrists 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="society">The Royal Australian and New Zealand College of Psychiatrists</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<boxed-text id="boxed-text1-0004867413491162">
<p>DSM Digest</p>
</boxed-text>
<p>There are no biomarkers in the <italic>Diagnostic and Statistical Manual of Mental Disorders</italic> (DSM)-5, though their inclusion was a goal to which the planners aspired (<xref ref-type="bibr" rid="bibr9-0004867413491162">Kupfer et al., 2002</xref>). What happened?</p>
<p>The main impediment was an unrealistic expectation – seeking certainty in biomarkers, yet tolerating the generally weak discriminative performance of definitional signs and symptoms. A misunderstanding clearly persists about how biomarkers are used in medicine. Most laboratory tests are probabilistic, not pathognomonic, markers of disease. They can assist in ruling in or ruling out diagnoses. Few have exceptional sensitivity and specificity, however, and, even if they do, their predictive value depends critically on disease prevalence. Phenylketonuria, with a prevalence of 1 in 10,000 births, is a case in point: even though neonatal screening tests for this condition have excellent sensitivity (100%) and specificity (99.95%), most positive test results are false positives (<xref ref-type="bibr" rid="bibr6-0004867413491162">Galen and Gambino, 1975</xref>). Expressed in Bayesian terms, <bold><italic>the prior probability matters</italic></bold>. This same principle applies when making diagnoses, whether relying on symptoms or biomarkers. As the various DSMs have demonstrated, less than perfectly discriminative symptoms can be of some use in diagnosis. Likewise, less than perfect biomarkers can be useful in guiding diagnosis and prognosis. The glucose tolerance test and the electroencephalogram are good examples (<xref ref-type="bibr" rid="bibr5-0004867413491162">DECODE Study Group, 2001</xref>; <xref ref-type="bibr" rid="bibr7-0004867413491162">Goodin and Aminoff, 1984</xref>).</p>
<p>Some key principles apply. First, an iterative approach is essential (<xref ref-type="bibr" rid="bibr2-0004867413491162">Carroll, 1989</xref>). Failure to understand this principle dooms efforts to develop biomarkers. We know that current, symptom-based definitions of psychiatric disorders are just placeholders, limited by etiologic heterogeneity and unimpressive reliability or stability, so it is illogical to treat these as unquestioned gold standards. Second, longitudinal studies are needed to complement cross-sectional studies. There are several reports of apparently false positive biomarkers being reconsidered true positive in light of subsequent diagnostic change (<xref ref-type="bibr" rid="bibr2-0004867413491162">Carroll, 1989</xref>). That is a form of iteration. Third, making a diagnosis is not the same as defining a disorder: diagnoses are casewise probability estimates, subject to revision as new information arrives. That new information <italic>may be independent of the defining DSM criteria</italic>. For example, clinically salient features such as family history and course of illness are excluded from DSM criteria, even though they are among the originally proposed validators of psychiatric diagnosis (<xref ref-type="bibr" rid="bibr10-0004867413491162">Robins and Guze, 1970</xref>). In practice, establishing a family history of recurrent depression or suicide can shift the probability of melancholic depression from 50% in an ambiguous case to 80%, which is the usual treatment threshold (<xref ref-type="bibr" rid="bibr3-0004867413491162">Carroll, 2012</xref>). Biomarkers operate in the same way. The incremental confidence they provide is case specific, and the resulting change of diagnostic certainty depends on the prior probability of the diagnosis for that patient. Diagnostic use of electroencephalography (EEG) in suspected epilepsy illustrates these principles nicely (<xref ref-type="bibr" rid="bibr2-0004867413491162">Carroll, 1989</xref>; <xref ref-type="bibr" rid="bibr7-0004867413491162">Goodin and Aminoff, 1984</xref>). Bayes’ theorem provides the statistical basis of this iterative differential diagnostic process (<xref ref-type="bibr" rid="bibr1-0004867413491162">Bianchi and Alexander, 2006</xref>).</p>
<p>A case example will demonstrate the Bayesian application of biomarkers in psychiatric diagnosis. A disheveled elderly gentleman presents with depressive, psychotic, and cognitive features of uncertain duration. The referring physician suggests psychotic depression with mood-related cognitive change. The emergency room physician suggests schizophrenia with negative symptoms and demoralization. The inpatient chief resident says rule out dementia with apathy and delusions. The attending psychiatrist estimates the probabilities of these differential diagnoses at 65%, 20%, and 15%, respectively. These <italic>prior probabilities</italic> are shown in <xref ref-type="table" rid="table1-0004867413491162">Table 1</xref>. A dexamethasone suppression test (DST) (<xref ref-type="bibr" rid="bibr4-0004867413491162">Carroll et al., 1981</xref>) is now performed. The typical rates of positive and negative DSTs for each candidate diagnosis are shown. These are termed <italic>conditional probabilities</italic>. After a positive DST result is found, Bayes’ theorem updates the probabilities of each candidate diagnosis in light of the test result and of the prior and conditional probabilities. These updates are shown as revised or <italic>posterior probabilities</italic>. The probability of psychotic depression increases from 65% to 82%, and the probability of each alternative diagnosis decreases. This result occurs despite the fact that the specificity of the DST is far from perfect – it is 80% for schizophrenia and only 65% for dementia. In general, the weaker the specificity of the test (and most are indeed weak) the more <bold><italic>the prior probability matters</italic></bold>. If a negative test result were obtained then the revised diagnostic probabilities would be as <xref ref-type="table" rid="table1-0004867413491162">Table 1</xref> also shows: psychotic depression would still be the most likely diagnosis. These observations demonstrate that the DST (and most other, similar tests) serve primarily to rule in rather than to rule out the leading candidate diagnosis.</p>
<table-wrap id="table1-0004867413491162" position="float">
<label>Table 1.</label>
<caption>
<p>Case illustration of Bayesian application of biomarkers (DST then REM latency).</p>
</caption>
<graphic alternate-form-of="table1-0004867413491162" xlink:href="10.1177_0004867413491162-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Possible diagnoses</th>
<th align="left">Psychotic depression</th>
<th align="left">Schizophrenia</th>
<th align="left">Dementia</th>
</tr>
</thead>
<tbody>
<tr>
<td><bold>Prior probabilities (clinical differential diagnosis)</bold></td>
<td>0.65</td>
<td>0.20</td>
<td>0.15</td>
</tr>
<tr>
<td colspan="4"><italic>DST conditional probabilities</italic></td>
</tr>
<tr>
<td>Test positive rate expected (DST +)</td>
<td>0.65</td>
<td>0.20</td>
<td>0.35</td>
</tr>
<tr>
<td>Test negative rate expected (DST –)</td>
<td>0.35</td>
<td>0.80</td>
<td>0.65</td>
</tr>
<tr>
<td colspan="4"><italic>Posterior (revised) probabilities</italic></td>
</tr>
<tr>
<td>Test positive result (DST +)</td>
<td>0.82</td>
<td>0.08</td>
<td>0.10</td>
</tr>
<tr>
<td>Test negative result (DST –)</td>
<td>0.47</td>
<td>0.33</td>
<td>0.20</td>
</tr>
<tr>
<td><bold>New prior probabilities (after positive DST)</bold></td>
<td>0.82</td>
<td>0.08</td>
<td>0.10</td>
</tr>
<tr>
<td colspan="4"><italic>Sleep EEG conditional probabilities</italic></td>
</tr>
<tr>
<td>Test positive rate expected (short REM latency)</td>
<td>0.65</td>
<td>0.20</td>
<td>0.10</td>
</tr>
<tr>
<td>Test negative rate expected (normal REM latency)</td>
<td>0.35</td>
<td>0.80</td>
<td>0.90</td>
</tr>
<tr>
<td colspan="4"><italic>Posterior (revised) probabilities</italic></td>
</tr>
<tr>
<td>Test positive result (short REM latency)</td>
<td>0.95</td>
<td>0.03</td>
<td>0.02</td>
</tr>
<tr>
<td>Test negative result (normal REM latency)</td>
<td>0.65</td>
<td>0.15</td>
<td>0.20</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0004867413491162">
<p>DST: dexamethasone suppression test; EEG: electroencephalography; REM: rapid eye movement.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Sequential testing can further improve diagnostic confidence. Here the DST was followed by a sleep EEG study which was positive for short rapid eye movement latency. Now, we use the previously calculated posterior probabilities as new priors in further updating the probabilities (another example of iterative reasoning). As <xref ref-type="table" rid="table1-0004867413491162">Table 1</xref> shows, the sleep EEG resembles the DST in sensitivity and specificity, yet the updated diagnostic probabilities after two positive results will be 0.95, 0.03, and 0.02 (<xref ref-type="table" rid="table1-0004867413491162">Table 1</xref>): there is an asymptote towards high diagnostic confidence (65% → 82% → 95%). The new test has again been useful for ruling in (not ruling out) the leading diagnostic formulation. These computations can be done online, for instance, through: <ext-link ext-link-type="uri" xlink:href="http://statpages.org/bayes.html">statpages.org/bayes.html</ext-link>. Other combinations of outcomes also can be examined, and candidate biomarkers for other disorders can be assessed in a like manner.</p>
<p>This example illustrates the reality of clinical uncertainty, confirming Spitzer’s dictum that ‘<italic>The use of specified criteria does not … eliminate clinical judgment …</italic>’ (<xref ref-type="bibr" rid="bibr11-0004867413491162">Spitzer et al., 1978</xref>). Indeed, the various DSMs are not designed for making diagnoses, much less differential diagnoses. The DSMs serve, rather, to document that diagnoses made under conditions of clinical uncertainty conform to a minimum symptom profile (<xref ref-type="bibr" rid="bibr3-0004867413491162">Carroll, 2012</xref>). The current DSMs are innumerate in not providing a Bayesian approach to differential diagnosis. Instead, they merely stipulate signs and symptoms in disjunctive format (the so-called Chinese menu approach), without stating sensitivity and specificity measures. It is possible to improve the confidence of DSM-III diagnoses by considering specific combinations of symptoms when their discriminative performances are known (<xref ref-type="bibr" rid="bibr12-0004867413491162">Widiger et al., 1984</xref>), but this approach was not adopted in later DSMs.</p>
<p>A frequent reservation about the Bayesian approach to diagnosis is that the judgment of casewise prior probabilities will vary, perhaps widely, from one clinician or unit to another. Such variance may simply reflect the reality that some clinicians are more astute than others (<xref ref-type="bibr" rid="bibr13-0004867413491162">Wolf et al., 1985</xref>). An urgent goal of research will be to establish and maintain cumulative large data sets so that such variance is minimized (<xref ref-type="bibr" rid="bibr8-0004867413491162">Goodman, 2009</xref>). A Bayes-informed approach to symptoms, biomarkers, family history, and course of illness would be a welcome advance to improve diagnostic confidence in DSM-6. Haste the day.</p>
</body>
<back>
<ack>
<p>The author thanks John CS Breitner, MD, who helpfully reviewed early drafts of this manuscript. No duplicate submissions were made to other journals.</p>
</ack>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</fn>
<fn fn-type="conflict">
<label>Declaration of interest</label>
<p>The author declares no competing financial or professional interests. This commentary was commissioned by the Editor-in-Chief.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0004867413491162">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bianchi</surname><given-names>MT</given-names></name>
<name><surname>Alexander</surname><given-names>BM</given-names></name>
</person-group> (<year>2006</year>) <article-title>Evidence based diagnosis: Does the language fit the theory?</article-title> <source>British Medical Journal</source> <volume>333</volume>: <fpage>442</fpage>–<lpage>445</lpage>.</citation>
</ref>
<ref id="bibr2-0004867413491162">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Carroll</surname><given-names>BJ</given-names></name>
</person-group> (<year>1989</year>) <article-title>Diagnostic validity and laboratory studies: Rules of the game</article-title>. In: <person-group person-group-type="editor">
<name><surname>Robins</surname><given-names>LN</given-names></name>
<name><surname>Barrett</surname><given-names>JN</given-names></name>
</person-group> (eds) <source>The Validity of Psychiatric Diagnosis</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Raven Press</publisher-name>, pp. <fpage>229</fpage>–<lpage>245</lpage>.</citation>
</ref>
<ref id="bibr3-0004867413491162">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carroll</surname><given-names>BJ</given-names></name>
</person-group> (<year>2012</year>) <article-title>Bringing back melancholia</article-title>. <source>Bipolar Disorders</source> <volume>14</volume>: <fpage>1</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr4-0004867413491162">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carroll</surname><given-names>BJ</given-names></name>
<name><surname>Feinberg</surname><given-names>M</given-names></name>
<name><surname>Greden</surname><given-names>J</given-names></name><etal/>
</person-group>. (<year>1981</year>) <article-title>A specific laboratory test for the diagnosis of melancholia</article-title>. <source>Archives of General Psychiatry</source> <volume>38</volume>: <fpage>15</fpage>–<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr5-0004867413491162">
<citation citation-type="journal">
<collab>DECODE Study Group</collab> (<year>2001</year>) <article-title>Glucose tolerance and cardiovascular mortality: Comparison of fasting and 2-hour diagnostic criteria</article-title>. <source>Archives of Internal Medicine</source> <volume>161</volume>: <fpage>397</fpage>–<lpage>404</lpage>.</citation>
</ref>
<ref id="bibr6-0004867413491162">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Galen</surname><given-names>RS</given-names></name>
<name><surname>Gambino</surname><given-names>SR</given-names></name>
</person-group> (<year>1975</year>) <source>Beyond Normality: The Predictive Value and Efficiency of Medical Diagnoses</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Wiley</publisher-name>.</citation>
</ref>
<ref id="bibr7-0004867413491162">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Goodin</surname><given-names>DS</given-names></name>
<name><surname>Aminoff</surname><given-names>MJ</given-names></name>
</person-group> (<year>1984</year>) <article-title>Does the interictal EEG have a role in the diagnosis of epilepsy?</article-title> <source>Lancet</source> <volume>i</volume>: <fpage>837</fpage>–<lpage>839</lpage>.</citation>
</ref>
<ref id="bibr8-0004867413491162">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Goodman</surname><given-names>SN</given-names></name>
</person-group> (<year>2009</year>) <article-title>Building a Bayesian bridge from evidence to guidelines</article-title>. <source>Archives of Internal Medicine</source> <volume>169</volume>: <fpage>1436</fpage>–<lpage>1437</lpage>.</citation>
</ref>
<ref id="bibr9-0004867413491162">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Kupfer</surname><given-names>D</given-names></name>
<name><surname>First</surname><given-names>M</given-names></name>
<name><surname>Regier</surname><given-names>D</given-names></name>
</person-group> (<year>2002</year>) <source>A Research Agenda for DSM-V</source>. <publisher-loc>Arlington, VA</publisher-loc>: <publisher-name>American Psychiatric Association</publisher-name>.</citation>
</ref>
<ref id="bibr10-0004867413491162">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Robins</surname><given-names>E</given-names></name>
<name><surname>Guze</surname><given-names>SB</given-names></name>
</person-group> (<year>1970</year>) <article-title>Establishment of diagnostic validity in psychiatric illness: Its application to schizophrenia</article-title>. <source>American Journal of Psychiatry</source> <volume>126</volume>: <fpage>983</fpage>–<lpage>987</lpage>.</citation>
</ref>
<ref id="bibr11-0004867413491162">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Spitzer</surname><given-names>RL</given-names></name>
<name><surname>Endicott</surname><given-names>J</given-names></name>
<name><surname>Robins</surname><given-names>E</given-names></name>
</person-group> (<year>1978</year>) <article-title>Research diagnostic criteria: Rationale and reliability</article-title>. <source>Archives of General Psychiatry</source> <volume>35</volume>: <fpage>773</fpage>–<lpage>782</lpage>.</citation>
</ref>
<ref id="bibr12-0004867413491162">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Widiger</surname><given-names>TA</given-names></name>
<name><surname>Hurt</surname><given-names>SW</given-names></name>
<name><surname>Frances</surname><given-names>A</given-names></name><etal/>
</person-group>. (<year>1984</year>) <article-title>Diagnostic efficiency and DSM-III</article-title>. <source>Archives of General Psychiatry</source> <volume>41</volume>: <fpage>1005</fpage>–<lpage>1012</lpage>.</citation>
</ref>
<ref id="bibr13-0004867413491162">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wolf</surname><given-names>FM</given-names></name>
<name><surname>Gruppen</surname><given-names>LD</given-names></name>
<name><surname>Billi</surname><given-names>JE</given-names></name>
</person-group> (<year>1985</year>) <article-title>Differential diagnosis and the competing-hypotheses heuristic</article-title>. <source>Journal of the American Medical Association</source> <volume>253</volume>: <fpage>2858</fpage>–<lpage>2862</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>